SLRX vs WAT · $4.9M cap vs P/E 32, rev $3.17B
Salarius Pharmaceuticals Inc (SLRX) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
SLRX currently screens at market cap $4.9M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the SLRX and WAT stock pages for the full models.
Not investment advice.